Binimetinib and Encorafenib for the Treatment of Pancreatic Cancer in Patients With a Somatic BRAF V600E Mutation

Clinical trial NCT04390243 · TERMINATED

Trial details

NCT number: NCT04390243
Sponsor: Academic and Community Cancer Research United
Status: TERMINATED
Phase: Phase 2
Study type: INTERVENTIONAL

Locally Advanced Pancreatic Carcinoma Metastatic Pancreatic Carcinoma Recurrent Pancreatic Carcinoma Stage III Pancreatic Cancer AJCC v8 Stage IV Pancreatic Cancer AJCC v8

Start date: 2020-11-16
Primary completion: 2023-11-01
Enrollment: 6

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.